Noidecs Medical Cannabis Line Returns to Lyphe Dispensary as Supply Stability Improves

After a turbulent period for medical cannabis imports in the UK, Lyphe Dispensary has announced that five Noidecs flower products are officially back on shelves, with additional items expected to return over the coming month and throughout 2026. This reintroduction restores a key affordable product line that many patients had come to depend on before the October 2024 restrictions.

The past year’s limited supply landscape left very few choices for patients and clinicians. With Lyphe Dispensary’s latest update, the outlook is shifting, signalling the return of broader product availability and offering more competitively priced options outside the dominant supplier currently shaping the market.

The reinstated Noidecs collection includes T18, T19, T21 and the higher-strength T23/T24 strains. These products cover a wide spectrum of THC levels and terpene arrangements, giving prescribers greater flexibility when selecting treatments suited to individual therapeutic needs.

All updated product information can now be viewed on the Lyphe Dispensary formulary by patients who meet the prescribing criteria. Existing account holders will need to log in to see the complete details.

“Patients have been asking for the return of Noidecs, and we’re thrilled to be able to finally deliver,” said Karen Sharp, Managing Director at Lyphe Clinic.

“It’s been a bumpy road, but our focus has always been on improving patient choice and access while maintaining affordability and quality. The return of this popular brand, Noidecs, underlines our ongoing efforts and commitment to a sustainable and patient-first supply model.”

“In the near future, we look forward to being able to provide patients with a broader range of Noidecs treatment options, catering for patients who use non-flower-based products such as oils and vapes. But one step at a time!”

The development reinforces Lyphe Dispensary’s goal of widening the availability of affordable and diverse medicinal cannabis solutions across the UK and Channel Islands.

Cultivated with sustainability, reliability, and affordability in mind, all Noidecs products offer patients fresh, high-quality cannabis-based medicines without excessive cost.

To find out more about Lyphe Dispensary, their services, or recent news, visit lyphedispensary.com.

About Lyphe Dispensary

Lyphe Dispensary (formerly Dispensary Green) have been around since 2019 and is one of the UK’s leading dispensers of CBMPs (Cannabis-Based Medicinal Products), supporting patients through their treatment journey. Focused on affordability, accessibility, and clinical excellence, Lyphe Dispensary continues to expand its formulary with responsible leadership within the medical cannabis industry.

Leave a Reply

Your email address will not be published. Required fields are marked *